Recent Work
-
Knowledge and Attitudes Concerning Aducanumab Among Older Americans After FDA Approval for Treatment of Alzheimer Disease
Schaeffer Center researchers have found older Americans know little about aducanumab, despite the fact that an overwhelming majority of survey respondents said they were worried about Alzheimer’s disease.
-
Racial/Ethnic Disparities in Length of Life after Dementia Diagnosis: an 18-Year Follow-up Study of Medicare Beneficiaries
Quantifying survival time after dementia diagnosis and assessing mechanisms driving differences across race/ethnicity to inform care and financial planning.